GB0708021D0 - Use - Google Patents

Use

Info

Publication number
GB0708021D0
GB0708021D0 GB0708021A GB0708021A GB0708021D0 GB 0708021 D0 GB0708021 D0 GB 0708021D0 GB 0708021 A GB0708021 A GB 0708021A GB 0708021 A GB0708021 A GB 0708021A GB 0708021 D0 GB0708021 D0 GB 0708021D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0708021A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cyclacel Ltd
Original Assignee
Cyclacel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyclacel Ltd filed Critical Cyclacel Ltd
Priority to GB0708021A priority Critical patent/GB0708021D0/en
Publication of GB0708021D0 publication Critical patent/GB0708021D0/en
Priority to EP08737080.5A priority patent/EP2148676B1/en
Priority to PL08737080.5T priority patent/PL2148676T3/en
Priority to PCT/GB2008/001424 priority patent/WO2008132443A1/en
Priority to ES08737080.5T priority patent/ES2587381T3/en
Priority to JP2010504828A priority patent/JP5852309B2/en
Priority to US12/597,293 priority patent/US8536188B2/en
Priority to US13/967,901 priority patent/US9675631B2/en
Priority to JP2014170018A priority patent/JP5892565B2/en
Ceased legal-status Critical Current

Links

GB0708021A 2007-04-25 2007-04-25 Use Ceased GB0708021D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB0708021A GB0708021D0 (en) 2007-04-25 2007-04-25 Use
EP08737080.5A EP2148676B1 (en) 2007-04-25 2008-04-24 Use of sapacitabine to treat proliferative disease
PL08737080.5T PL2148676T3 (en) 2007-04-25 2008-04-24 Use of sapacitabine to treat proliferative disease
PCT/GB2008/001424 WO2008132443A1 (en) 2007-04-25 2008-04-24 Use of sapacitabine to treat proliferative disease
ES08737080.5T ES2587381T3 (en) 2007-04-25 2008-04-24 Use of sapacitabine to treat a proliferative disease
JP2010504828A JP5852309B2 (en) 2007-04-25 2008-04-24 Use of sapacitabine to treat proliferative diseases
US12/597,293 US8536188B2 (en) 2007-04-25 2008-04-24 Dosing regimens for treatment of proliferative disorders comprising administration of sapacitabine
US13/967,901 US9675631B2 (en) 2007-04-25 2013-08-15 Dosing regimens for treatment of proliferative disorders comprising administration of sapacitabine
JP2014170018A JP5892565B2 (en) 2007-04-25 2014-08-25 Use of sapacitabine to treat proliferative diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0708021A GB0708021D0 (en) 2007-04-25 2007-04-25 Use

Publications (1)

Publication Number Publication Date
GB0708021D0 true GB0708021D0 (en) 2007-06-06

Family

ID=38170676

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0708021A Ceased GB0708021D0 (en) 2007-04-25 2007-04-25 Use

Country Status (1)

Country Link
GB (1) GB0708021D0 (en)

Similar Documents

Publication Publication Date Title
GB0700580D0 (en) Use
EP2212908A4 (en) Fin-jfet
DE602008005470D1 (en) Imidazopyridinone
GB0822552D0 (en) New use
GB0705915D0 (en) New use
EP2160187A4 (en) Spiroindalones
AP2010005314A0 (en) Nanodispersian
EP2211752A4 (en) Biopulp
GB0714670D0 (en) Use
GB0712503D0 (en) Use
GB2450608B (en) New use
GB0706787D0 (en) Novel use
IL183496A0 (en) Single use sinkstainer
GB0723519D0 (en) Novel use
GB0723523D0 (en) Novel use
GB0701096D0 (en) Use
DE602008004135D1 (en) Triphenylmethan- und xanthenpigmente
GB0723723D0 (en) Use
GB0714155D0 (en) use
GB0708021D0 (en) Use
AU3606P (en) Jaywick xTriticosecale
AU3595P (en) Goldust Strobilanthes anisophyllus
AU3952P (en) FLOCHRDEF Chrysocephalum apiculatum
AU3702P (en) DarwinGold Dianella ensifolia
AU3646P (en) TAS300 Dianella tasmanica

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)